Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. (Q53873539)
Jump to navigation
Jump to search
scientific article published in May 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. |
scientific article published in May 2002 |
Statements
Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. (English)
James G Krueger
Alice B Gottlieb
Knut Wittkowski
Russell Dedrick
Patricia Ann Walicke
Marvin Garovoy
1 May 2002
138
5
591-600